Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. - Wikidata - awgldk - TriplyDB

Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

http://www.wikidata.org/entity/Q37734096

about

Role of sulfatide in normal and pathological cells and tissues A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.The Role of Lipids in Retrovirus Replication.Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.Polymeric drugs: Advances in the development of pharmacologically active polymers.Surface-engineered dendrimers: a solution for toxicity issues.Dendrimers as therapeutic agents: a systematic review.Dendrimers as potential therapeutic tools in HIV inhibition.Polymeric anti-HIV therapeutics.Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.Role of sulfatide in vaccinia virus infection.Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.Dendritic catanionic assemblies: in vitro anti-HIV activity of phosphorus-containing dendrimers bearing galbeta1cer analogues.Influence of Structural Parameters on the Self-Association Properties of Anti-HIV Catanionic Dendrimers.Dendrimeric based microbicides against sexual transmitted infections associated to heparan sulfate Dendrimers as topical microbicides with activity against HIV Unexpected Biological Applications of Dendrimers and Specific Multivalency Activities

P2860

Q28267288-5EA62373-EDC4-4AC1-8E3E-F34D0F0A27E2 Q30431343-944AFD1B-03B1-4794-8BAA-1976F59AFFAB Q34080779-7A6AF56D-2ED3-46FC-B953-2DBE1BFCF945 Q34253227-EF0DBABF-7644-4494-A03C-6A7D90FF5D80 Q36307604-CC9CE757-BC73-44B7-A961-DAFBBC78BCAD Q37372870-BD9A505B-314F-41DC-9D92-87C23CFF7CCE Q37585659-DC4BF26A-634D-48AE-BDBF-C25B4A93AF5D Q38123954-E619B984-E0E2-46C9-82B6-49CB4CF64C84 Q38245819-6D612F99-E056-48B9-A63B-5AAF2D3853F1 Q38292341-ED5516B8-7DAE-444C-9DEA-DB585B0BB3CD Q38925952-ED34A14A-93E4-4002-AFC8-E6024CBE087C Q39545996-698FDB34-B236-471A-8217-E718DCBEDCB0 Q39885075-5F86ECD1-38FD-4A15-BAA2-3CFD7173F134 Q40345874-42203505-A4E7-41A6-B4CA-D62FB1FC2893 Q41349667-0CC046F0-F549-4537-BE10-1BA3EEB9715C Q57079901-5E534DEC-2A0E-46D5-A829-5A5A774E7B16 Q57079961-A1DBA662-AE01-4CB0-816F-D20943DA8864 Q57340548-65A8267B-5EE6-4072-A2B1-AD90F9561906

P2860

Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

http://www.wikidata.org/entity/Q37734096

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel polysulfated galactose-d ...... ciency virus type 1 infection.

@en

Novel polysulfated galactose-d ...... ciency virus type 1 infection.

@nl

type

label

Novel polysulfated galactose-d ...... ciency virus type 1 infection.

@en

Novel polysulfated galactose-d ...... ciency virus type 1 infection.

@nl

prefLabel

Novel polysulfated galactose-d ...... ciency virus type 1 infection.

@en

Novel polysulfated galactose-d ...... ciency virus type 1 infection.

@nl

P1433

Q37734096-B05B3DA3-01C7-483D-A2D2-4E1EADB71FBE

P1476

Q37734096-A26CE31D-010C-4412-BC98-B73667FCA326

P2093

Q37734096-0044419E-2793-41A6-8C40-0BCBE18F0869

Q37734096-0E4068C1-DFCD-4B60-BF3A-CE55B920F943

Q37734096-320016A0-96D9-4778-A505-4EA2A7DAD0F6

Q37734096-C42707FD-5ECB-4B4E-87E7-CE49B9FE24A6

Q37734096-F1E4AA71-3DFD-4DFA-AE10-24879F418796

P2860

Q37734096-06BD7A5C-4FD9-400A-AC14-0B135DE6DC67

Q37734096-06CFBD5C-02CC-47C1-821E-FB1869BBF8C7

Q37734096-0BAFB577-71D7-4A23-997E-DD80F6FF07D5

Q37734096-10C2ABEE-7827-4FB9-88F9-AA6BEF925ED0

Q37734096-148396C2-C354-4A82-B0D2-16941CDDEA24

Q37734096-1951F9B9-01A7-4EA0-9629-CA94157555C1

Q37734096-20DDA3C0-9933-4CB8-B155-941E149A4DEB

Q37734096-2ABE5903-1AC5-4674-B862-CCC2DD21CD99

Q37734096-382F6EDD-54B0-4D82-ADA4-FA05130066B1

Q37734096-3E59D384-FDEA-4A94-B8B2-38406BB4EB20

P304

Q37734096-BD98BCBF-8213-4A74-AEF6-BE3BD2BCD541

P31

Q37734096-0C6E53C4-0A4C-4B36-B37F-D76690938731

P356

Q37734096-7D01B5EE-E89B-4E95-9567-DDBF9948D91F

P407

Q37734096-D3CD02C0-9000-43F8-A599-546A7EAB8D06

P433

Q37734096-158BE843-21CC-45C6-8028-367F5AC165CD

P478

Q37734096-44DE6E70-8535-4466-A05C-9E63C2BF8F5B

P577

Q37734096-FB7852F2-5320-4854-9BDA-BB501977E89B

P5875

Q37734096-A33118A4-9E12-46D4-96D7-737055C6DDAB

P698

Q37734096-2602FC62-78FD-4BB9-AD81-5F7CE4C834FD

P932

Q37734096-C6E2593E-4689-43AA-A819-E2BB69672E28

P356

AAC.48.5.1614-1623.2004

P1433

Antimicrobial Agents and Chemotherapy

P1476

Novel polysulfated galactose-d ...... ciency virus type 1 infection.

@en

P2093

Bradley J Catalone

http://www.w3.org/2001/XMLSchema#string

Brian Wigdahl

http://www.w3.org/2001/XMLSchema#string

Cara-Lynne Schengrund

http://www.w3.org/2001/XMLSchema#string

Fred C Krebs

http://www.w3.org/2001/XMLSchema#string

Richard D Kensinger

http://www.w3.org/2001/XMLSchema#string

P2860

Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Atomic structure of the ectodomain from HIV-1 gp41

Functional rafts in cell membranes

Lipid rafts and signal transduction

HIV entry and its inhibition

In vitro anti-HIV-1 activity of chondroitin polysulphate

Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

P304

1614-1623

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.5.1614-1623.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8600027

http://www.w3.org/2001/XMLSchema#string

P698

15105112

http://www.w3.org/2001/XMLSchema#string

P932

400553

http://www.w3.org/2001/XMLSchema#string